| Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol … C Ireson, S Orr, DJL Jones, R Verschoyle, CK Lim, JL Luo, L Howells, ... Cancer research 61 (3), 1058-1064, 2001 | 850 | 2001 |
| Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine CR Ireson, DJL Jones, S Orr, MWH Coughtrie, DJ Boocock, ML Williams, ... Cancer Epidemiology Biomarkers & Prevention 11 (1), 105-111, 2002 | 820 | 2002 |
| Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences G Garcea, DP Berry, DJL Jones, R Singh, AR Dennison, PB Farmer, ... Cancer Epidemiology Biomarkers & Prevention 14 (1), 120-125, 2005 | 662 | 2005 |
| Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients KR Patel, VA Brown, DJL Jones, RG Britton, D Hemingway, AS Miller, ... Cancer research 70 (19), 7392-7399, 2010 | 653 | 2010 |
| Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration G Garcea, DJL Jones, R Singh, AR Dennison, PB Farmer, RA Sharma, ... British journal of cancer 90 (5), 1011-1015, 2004 | 569 | 2004 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 500 | 2021 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 311 | 2022 |
| Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3, 4, 5, 4 … S Sale, RD Verschoyle, D Boocock, DJL Jones, N Wilsher, KC Ruparelia, ... British journal of cancer 90 (3), 736-744, 2004 | 303 | 2004 |
| Trimethylamine N-oxide and prognosis in acute heart failure T Suzuki, LM Heaney, SS Bhandari, DJL Jones, LL Ng Heart 102 (11), 841-848, 2016 | 251 | 2016 |
| Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction T Suzuki, LM Heaney, DJL Jones, LL Ng Clinical chemistry 63 (1), 420-428, 2017 | 155 | 2017 |
| Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration—a clinical pilot study including assessment of patient acceptability GRB Irving, LM Howells, S Sale, I Kralj-Hans, WS Atkin, SK Clark, ... Cancer prevention research 6 (2), 119-128, 2013 | 128 | 2013 |
| DNA adducts: mass spectrometry methods and future prospects PB Farmer, K Brown, E Tompkins, VL Emms, DJL Jones, R Singh, ... Toxicology and applied pharmacology 207 (2), 293-301, 2005 | 124 | 2005 |
| The human apoptosis-inducing protein AMID is an oxidoreductase with a modified flavin cofactor and DNA binding activity KR Marshall, M Gong, L Wodke, JH Lamb, DJL Jones, PB Farmer, ... Journal of Biological Chemistry 280 (35), 30735-30740, 2005 | 113 | 2005 |
| Curcumin ameliorates oxaliplatin‐induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo LM Howells, S Sale, SN Sriramareddy, GRB Irving, DJL Jones, CJ Ottley, ... International journal of cancer 129 (2), 476-486, 2011 | 111 | 2011 |
| Vitamin D and prognosis in acute myocardial infarction LL Ng, JK Sandhu, IB Squire, JE Davies, DJL Jones International journal of cardiology 168 (3), 2341-2346, 2013 | 108 | 2013 |
| Association with outcomes and response to treatment of trimethylamine N‐oxide in heart failure: results from BIOSTAT‐CHF T Suzuki, Y Yazaki, AA Voors, DJL Jones, DCS Chan, SD Anker, ... European journal of heart failure 21 (7), 877-886, 2019 | 85 | 2019 |
| Proenkephalin, renal dysfunction, and prognosis in patients with acute heart failure: a GREAT network study LL Ng, IB Squire, DJL Jones, TH Cao, DCS Chan, JK Sandhu, PA Quinn, ... Journal of the American college of cardiology 69 (1), 56-69, 2017 | 85 | 2017 |
| Proenkephalin and prognosis after acute myocardial infarction LL Ng, JK Sandhu, H Narayan, PA Quinn, IB Squire, JE Davies, ... Journal of the American College of Cardiology 63 (3), 280-289, 2014 | 83 | 2014 |
| Notch3 and HEY-1 as prognostic biomarkers in pancreatic adenocarcinoma CD Mann, C Bastianpillai, CP Neal, MM Masood, DJL Jones, F Teichert, ... PloS one 7 (12), e51119, 2012 | 71 | 2012 |
| A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer I Garrido-Laguna, KA McGregor, M Wade, J Weis, W Gilcrease, L Burr, ... Investigational new drugs 31, 1257-1264, 2013 | 67 | 2013 |
Leong NgUniversity of Leicester在 le.ac.uk 的电子邮件经过验证
